1. Home
  2. VIR vs CNXN Comparison

VIR vs CNXN Comparison

Compare VIR & CNXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.16

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

CNXN

PC Connection Inc.

HOLD

Current Price

$66.89

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
CNXN
Founded
2016
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2019
1997

Fundamental Metrics

Financial Performance
Metric
VIR
CNXN
Price
$9.16
$66.89
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.43
N/A
AVG Volume (30 Days)
1.6M
48.8K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
1.26%
EPS Growth
17.49
N/A
EPS
N/A
0.68
Revenue
$68,556,000.00
N/A
Revenue This Year
$270.22
$6.24
Revenue Next Year
N/A
$4.39
P/E Ratio
N/A
$96.28
Revenue Growth
N/A
N/A
52 Week Low
$4.16
$54.97
52 Week High
$11.66
$71.17

Technical Indicators

Market Signals
Indicator
VIR
CNXN
Relative Strength Index (RSI) 40.54 68.18
Support Level $8.47 $56.14
Resistance Level $10.29 $66.89
Average True Range (ATR) 0.47 1.70
MACD -0.18 0.08
Stochastic Oscillator 0.72 87.35

Price Performance

Historical Comparison
VIR
CNXN

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

Share on Social Networks: